Javascript must be enabled to continue!
1378. Clinical Characteristics of Tuberculosis Among Patients with Cancer in an Endemic Country
View through CrossRef
Abstract
Background
Tuberculosis (TB) is an infection caused by reactivation of Mycobacterium tuberculosis. Decreasing host immune system plays an important role in pathophysiology especially in patients with human immunodeficiency virus (HIV) infection and transplant recipients. Exposure to immunosuppressive agents among patients with solid and hematologic malignancy is likely to increase risk of TB. However, characteristics of TB in this population remain scarce.
Methods
A single-center, retrospective descriptive study was conducted at King Chulalongkorn Memorial Hospital. Adult patients who developed TB between January 2008 and October 2018 after diagnosis of solid or hematologic malignancy were identified using ICD-10 code. Baseline, clinical characteristics, and treatment outcomes were collected.
Results
A total of 114 patients developed TB after diagnosis of malignancy including, 67 (58.8%) with solid tumor and 47 (41.2%) with hematologic malignancy. Lung cancer was the most common solid malignancy with TB (17.9%) followed by head and neck carcinoma (14.9%) and colorectal cancer (13.4%). For hematologic malignancies, non-Hodgkin’s lymphoma was the most common malignancy (53.2%) followed by leukemia (29.8%) and multiple myeloma (14.9%). Among patients who received immunosuppressive treatment, the mean onset of TB was 4.97 months (range 0.25 to 57 months) and 2.55 months (range 0.1 to 18 months) after treatment of solid and hematologic malignancies. Pulmonary and pleural involvement remained the most common site of infection in both groups. Mortality was highest among patients with hematologic malignancies (40.4%) while mortality in solid malignancies was 11.9%.
Conclusion
TB in patients with solid and hematologic malignancies contained substantial morbidity and mortality. Immunosuppressive agents and chemotherapy may play an important role especially in the endemic area.
Disclosures
All authors: No reported disclosures.
Oxford University Press (OUP)
Title: 1378. Clinical Characteristics of Tuberculosis Among Patients with Cancer in an Endemic Country
Description:
Abstract
Background
Tuberculosis (TB) is an infection caused by reactivation of Mycobacterium tuberculosis.
Decreasing host immune system plays an important role in pathophysiology especially in patients with human immunodeficiency virus (HIV) infection and transplant recipients.
Exposure to immunosuppressive agents among patients with solid and hematologic malignancy is likely to increase risk of TB.
However, characteristics of TB in this population remain scarce.
Methods
A single-center, retrospective descriptive study was conducted at King Chulalongkorn Memorial Hospital.
Adult patients who developed TB between January 2008 and October 2018 after diagnosis of solid or hematologic malignancy were identified using ICD-10 code.
Baseline, clinical characteristics, and treatment outcomes were collected.
Results
A total of 114 patients developed TB after diagnosis of malignancy including, 67 (58.
8%) with solid tumor and 47 (41.
2%) with hematologic malignancy.
Lung cancer was the most common solid malignancy with TB (17.
9%) followed by head and neck carcinoma (14.
9%) and colorectal cancer (13.
4%).
For hematologic malignancies, non-Hodgkin’s lymphoma was the most common malignancy (53.
2%) followed by leukemia (29.
8%) and multiple myeloma (14.
9%).
Among patients who received immunosuppressive treatment, the mean onset of TB was 4.
97 months (range 0.
25 to 57 months) and 2.
55 months (range 0.
1 to 18 months) after treatment of solid and hematologic malignancies.
Pulmonary and pleural involvement remained the most common site of infection in both groups.
Mortality was highest among patients with hematologic malignancies (40.
4%) while mortality in solid malignancies was 11.
9%.
Conclusion
TB in patients with solid and hematologic malignancies contained substantial morbidity and mortality.
Immunosuppressive agents and chemotherapy may play an important role especially in the endemic area.
Disclosures
All authors: No reported disclosures.
Related Results
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Studying cases of extrapulmonary tuberculosis in the National Center for Tuberculosis Control in Damascus
Studying cases of extrapulmonary tuberculosis in the National Center for Tuberculosis Control in Damascus
Abstract
Background :Tuberculosis (TB) is a major public health concern worldwide and is the 13th leading cause of death and the second deadliest infectious disease after C...
Immune mechanisms controlling tuberculosis-diabetes co-morbidity
Immune mechanisms controlling tuberculosis-diabetes co-morbidity
<p dir="ltr">Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis (M. tuberculosis), remains a leading global health concern, responsible for millions of inf...
Immune mechanisms controlling tuberculosis-diabetes co-morbidity
Immune mechanisms controlling tuberculosis-diabetes co-morbidity
<p dir="ltr">Tuberculosis (TB), caused by the bacterium Mycobacterium tuberculosis (M. tuberculosis), remains a leading global health concern, responsible for millions of inf...
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Edoxaban and Cancer-Associated Venous Thromboembolism: A Meta-analysis of Clinical Trials
Abstract
Introduction
Cancer patients face a venous thromboembolism (VTE) risk that is up to 50 times higher compared to individuals without cancer. In 2010, direct oral anticoagul...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract
Introduction
Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Are Cervical Ribs Indicators of Childhood Cancer? A Narrative Review
Abstract
A cervical rib (CR), also known as a supernumerary or extra rib, is an additional rib that forms above the first rib, resulting from the overgrowth of the transverse proce...
PATHOMORPHOSIS OF EXTRAPULMONARY TUBERCULOSIS IN CHILDREN
PATHOMORPHOSIS OF EXTRAPULMONARY TUBERCULOSIS IN CHILDREN
Aim. To study clinical and epidemiological aspects of pathomorphosis of extrapulmonary tuberculosis clinical forms.
Materials and Methods. Retrospective analysis of 138 case histo...

